z-logo
open-access-imgOpen Access
Immunoglobulin ( Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality
Author(s) -
Frostegård A. G.,
Hua X.,
Su J.,
Carrero J. J.,
Heimbürger O.,
Bárány P.,
Stenvinkel P.,
Frostegård J.
Publication year - 2013
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12181
Subject(s) - interquartile range , medicine , antiphospholipid syndrome , autoantibody , gastroenterology , antibody , hazard ratio , immunology , cardiolipin , area under the curve , phospholipid , biology , confidence interval , membrane , genetics
Summary The risk of premature death is high in haemodialysis ( HD ) patients. Antibodies against cardiolipin (anti‐ CL ) are thrombogenic in diseases such as systemic lupus erythematosus ( SLE) . CL is easily oxidized ( Ox ) and plays a role in apoptosis. In this work we studied immunoglobulin ( Ig)M anti‐ CL and anti‐ OxCL in HD ‐patients. We conducted an observational study with a prospective follow‐up examining the relationship between anti‐ CL , anti‐ OxCL and mortality risk in a well‐characterized cohort of 221 prevalent HD patients [56% men, median age 66 (interquartile range 51–74) years, vintage time 29 (15–58) months] with a mean follow‐up period of 41 (20–48 months). According to the receiver operator characteristic ( ROC ) analysis, anti‐ OxCL [area under the curve ( AUC ) 0·62, P  < 0·01], but not anti‐ CL ( AUC 0·52, P  = 0·2), is associated with mortality. In crude and adjusted C ox analysis, every log increase in anti‐ OxCL inversely predicted all‐cause [adjusted hazard ratios ( HR) 0·62 (0·43–0·89)] and CVD ‐related [adjusted HR 0·56 (0·32–0·98)] mortality. Patients with anti‐ OxCL levels below median also had increased all‐cause and cardiovascular disease ( CVD) ‐related mortality. Although anti‐ OxCL and anti‐phosphorylcholine ( PC) were related positively to each other (ρ = 0·57, P  < 0·01), patients with one or two of these autoantibody levels below the median were associated with an incrementally increased death risk. Anti‐ OxCL were co‐factor β2‐ GPI ‐independent; anti‐ CL from patients with anti‐phospholipid antibody syndrome were β2‐ GPI ‐dependent, while sera from HD ‐patients less so. Sera from healthy donors was not β2‐ GPI ‐dependent. Anti‐ OxCL IgM is β2‐glycoprotein 1 ( GPI) ‐independent and a novel biomarker; low levels are associated with death among HD patients (and high levels with decreased risk). Combination with anti‐ PC increases this association. Putative therapeutic implications warrant further investigation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom